Operative Results and Oncologic Outcomes of Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy (ALPPS) Versus Two-Stage Hepatectomy (TSH) in Patients with Unresectable Colorectal Liver Metastases: A Systematic Review and Meta-Analysis

[1]  T. Pawlik,et al.  Liver hypoxia as a trigger to liver regeneration: No more than another piece of the puzzle. , 2017, Surgery.

[2]  R. Wenger,et al.  Hypoxia of the growing liver accelerates regeneration , 2017, Surgery.

[3]  H. Baba,et al.  Outcome after associating liver partition and portal vein ligation for staged hepatectomy and conventional two‐stage hepatectomy for colorectal liver metastases , 2016, The British journal of surgery.

[4]  A. Petrou,et al.  Mechanistic insights of rapid liver regeneration after associating liver partition and portal vein ligation for stage hepatectomy , 2016, World journal of gastroenterology.

[5]  D. Raptis,et al.  Short Chemotherapy-Free Interval Improves Oncological Outcome in Patients Undergoing Two-Stage Hepatectomy for Colorectal Liver Metastases , 2016, Annals of Surgical Oncology.

[6]  K. Koda,et al.  Histologic features after surgery associating liver partition and portal vein ligation for staged hepatectomy versus those after hepatectomy with portal vein embolization. , 2016, Surgery.

[7]  B. Isaksson,et al.  Associating liver partition and portal vein ligation for staged hepatectomy in patients with colorectal liver metastases--Intermediate oncological results. , 2016, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[8]  A. Petrou,et al.  The ALPPS procedure as a novel “liver-first” approach in treating liver metastases of colon cancer: the first experience in Greek Cypriot area , 2016, World Journal of Surgical Oncology.

[9]  R. Poon,et al.  Safety of ALPPS Procedure by the Anterior Approach for Hepatocellular Carcinoma. , 2016, Annals of surgery.

[10]  G. Spolverato,et al.  Defining Post Hepatectomy Liver Insufficiency: Where do We stand? , 2015, Journal of Gastrointestinal Surgery.

[11]  D. Nagorney,et al.  Is the liver kinetic growth rate in ALPPS unprecedented when compared with PVE and living donor liver transplant? A multicentre analysis. , 2015, HPB : the official journal of the International Hepato Pancreato Biliary Association.

[12]  S. Truant,et al.  Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS): impact of the inter-stages course on morbi-mortality and implications for management. , 2015, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[13]  V. Ardiles,et al.  Associating liver partition and portal vein ligation for staged hepatectomy offers high oncological feasibility with adequate patient safety: a prospective study at a single center. , 2015, Annals of surgery.

[14]  I. Endo,et al.  Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS): short-term outcome, functional changes in the future liver remnant, and tumor growth activity. , 2015, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[15]  M. Donati,et al.  ALPPS and simultaneous right hemicolectomy - step one and resection of the primary colon cancer , 2015, World Journal of Surgical Oncology.

[16]  K. Bertens,et al.  Can we improve the morbidity and mortality associated with the associating liver partition with portal vein ligation for staged hepatectomy (ALPPS) procedure in the management of colorectal liver metastases? , 2015, Surgery.

[17]  M. Masetti,et al.  Strategies to Increase the Resectability of Patients with Colorectal Liver Metastases: A Multi-center Case-Match Analysis of ALPPS and Conventional Two-Stage Hepatectomy , 2015, Annals of Surgical Oncology.

[18]  D. Raptis,et al.  Early Survival and Safety of ALPPS: First Report of the International ALPPS Registry , 2014, Annals of surgery.

[19]  N. Kokudo,et al.  Favorable Outcome After Repeat Resection for Colorectal Liver Metastases , 2014, Annals of Surgical Oncology.

[20]  W. Lau,et al.  Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS): a new strategy to increase resectability in liver surgery. , 2014, International journal of surgery.

[21]  C. Tschuor,et al.  ALPPS Offers a Better Chance of Complete Resection in Patients with Primarily Unresectable Liver Tumors Compared with Conventional-Staged Hepatectomies: Results of a Multicenter Analysis , 2014, World Journal of Surgery.

[22]  C. Tschuor,et al.  Salvage parenchymal liver transection for patients with insufficient volume increase after portal vein occlusion -- an extension of the ALPPS approach. , 2013, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[23]  J. Shindoh,et al.  Analysis of the efficacy of portal vein embolization for patients with extensive liver malignancy and very low future liver remnant volume, including a comparison with the associating liver partition with portal vein ligation for staged hepatectomy approach. , 2013, Journal of the American College of Surgeons.

[24]  G. Fürst,et al.  In situ liver transection with portal vein ligation for rapid growth of the future liver remnant in two‐stage liver resection , 2013, The British journal of surgery.

[25]  M. Choti,et al.  Survival after liver resection in metastatic colorectal cancer: review and meta-analysis of prognostic factors , 2012, Clinical epidemiology.

[26]  J. Vauthey,et al.  Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS): what is gained and what is lost? , 2012, Annals of surgery.

[27]  J. Belghiti,et al.  Which limits to the "ALPPS" approach? , 2012, Annals of surgery.

[28]  P. Clavien,et al.  Playing Play-Doh to prevent postoperative liver failure: the "ALPPS" approach. , 2012, Annals of surgery.

[29]  H. Schlitt,et al.  Right Portal Vein Ligation Combined With In Situ Splitting Induces Rapid Left Lateral Liver Lobe Hypertrophy Enabling 2-Staged Extended Right Hepatic Resection in Small-for-Size Settings , 2012, Annals of surgery.

[30]  F. Saliba,et al.  Impact of Expanding Criteria for Resectability of Colorectal Metastases on Short- and Long-Term Outcomes After Hepatic Resection , 2011, Annals of surgery.

[31]  E. Vasile,et al.  Randomized trial of two induction chemotherapy regimens in metastatic colorectal cancer: an updated analysis. , 2011, Journal of the National Cancer Institute.

[32]  C. Mathers,et al.  Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 , 2010, International journal of cancer.

[33]  M. Gönen,et al.  Survival after hepatic resection for metastatic colorectal cancer: trends in outcomes for 1,600 patients during two decades at a single institution. , 2010, Journal of the American College of Surgeons.

[34]  E. Van Cutsem,et al.  Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer. , 2009, The New England journal of medicine.

[35]  D. Moher,et al.  Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement , 2009, PloS one.

[36]  N. Habib,et al.  Preoperative Portal Vein Embolization for Major Liver Resection: A Meta-Analysis , 2008, Annals of surgery.

[37]  E. Abdalla,et al.  Improving Resectability of Hepatic Colorectal Metastases: Expert Consensus Statement , 2006, Annals of Surgical Oncology.

[38]  I. Hozo,et al.  Estimating the mean and variance from the median, range, and the size of a sample , 2005, BMC medical research methodology.

[39]  P. Bachellier,et al.  A Two-Stage Hepatectomy Procedure Combined With Portal Vein Embolization to Achieve Curative Resection for Initially Unresectable Multiple and Bilobar Colorectal Liver Metastases , 2004, Annals of surgery.

[40]  F. Lévi,et al.  Five-Year Survival Following Hepatic Resection After Neoadjuvant Therapy for Nonresectable Colorectal [Liver] Metastases , 2001, Annals of Surgical Oncology.

[41]  H. Bismuth,et al.  Two-Stage Hepatectomy: A Planned Strategy to Treat Irresectable Liver Tumors , 2000, Annals of surgery.

[42]  M. Makuuchi,et al.  Recurrence of hepatocellular carcinoma after surgery , 1996, The British journal of surgery.

[43]  T. Pawlik,et al.  Parenchymal-sparing Hepatectomy as the New Doctrine in the Treatment of Liver-metastatic Colorectal Disease: Beyond Oncological Outcomes. , 2017, Anticancer research.

[44]  U. Neumann,et al.  ALPPS Procedure in Insufficient Hypertrophy After Portal Vein Embolization (PVE) , 2016, World Journal of Surgery.

[45]  A. Jemal,et al.  Cancer statistics, 2012 , 2012, CA: a cancer journal for clinicians.

[46]  D. Moher,et al.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. , 2009, Journal of clinical epidemiology.